TABLE 2
Comparison of SUV
FDG
and SUV
FLT
at Days 4 and 7
Treatment
Tracer SUV
D+4 (%)
D+7 (%)
P
Cyclophosphamide
18
F-FDG
−25.09
−3.91
0.00005
*
18
F-FLT
−26.07
−18.82
0.48
Temsirolimus
18
F-FDG
−26.58
−12.58
0.09
18
F-FLT
−21.09
−21.09
0.004
*
↵
*
Statistically significant at the
P
≤ 0.05 level.